Kasinger James R.insider trades
In SEC Form 4 filings, Kasinger James R. is listed as General Counsel and Secretary of CRISPR Therapeutics AG (CRSP). In the last 90 days, Kasinger James R. sold $797.2K of CRISPR Therapeutics AG (CRSP) on the open market and bought none. 2 of the 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CRSPCRISPR Therapeutics AG | General Counsel and Secretary | 9 | Oct 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CRSPCRISPR Therapeutics AG | Oct 14 | Oct 15 | S | 1,040 | $49.26 | Sale −$51,230 | 95,857 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 13 | Oct 15 | M | 2,113 | not reported | not reported | 96,897 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 13 | Oct 15 | M · derivative | 2,113 | not reported | not reported | not reported | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 6 | Oct 8 | M | 1,990 | $13.62 | $27,104 | 96,774 | Yes | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 6 | Oct 8 | S | 1,990 | $60.04 | Sale −$119,481 | 94,784 | Yes | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 6 | Oct 8 | M · derivative | 1,990 | $13.62 | $27,104 | 81,242 | Yes | Form 4 |
| CRSPCRISPR Therapeutics AG | Sep 22 | Sep 24 | M | 10,400 | $13.62 | $141,648 | 105,184 | Yes | Form 4 |
| CRSPCRISPR Therapeutics AG | Sep 22 | Sep 24 | S | 10,400 | $60.24 | Sale −$626,460 | 94,784 | Yes | Form 4 |
| CRSPCRISPR Therapeutics AG | Sep 22 | Sep 24 | M · derivative | 10,400 | $13.62 | $141,648 | 83,232 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.